Heptares Co-Founder Resigns as VP and CSO of Parent Company Sosei Post author:Sam Post published:January 18, 2018 Post category:BioPharma Dr. Marshall will leave Sosei at the end of February 2018. Source: BioSpace You Might Also Like <b>Trump's</b> Expected Policy Changes Have Propelled These 2 Biotechs to New Highs March 19, 2017 John Wiley & Sons, Inc. Announces As New EVP Of Publishing Business October 12, 2017 Former Biogen Exec Launches First Life Sciences Fund With $750 Million May 22, 2017
